HopeStage
Back to all studies
TerminatedNCT06155695

Auditory Control Enhancement (ACE) in Schizophrenia

Device studyAges 18–40United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 40 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 5, 2023
Recruitment status
Terminated
Enrollment listed in the registry
12
Sponsor
Brian A Coffman, PhD
Sponsor type
Individual investigator
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT06155695
Official title
Show the full official title

Targeting the Auditory Control Network With Auditory Control Enhancement (ACE) in Schizophrenia

Recruitment & locations

Terminated

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brian A Coffman, PhD.

Who can participate?

Listed age limits: 18 years to 40 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies